<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04473313</url>
  </required_header>
  <id_info>
    <org_study_id>EDURESPI (29BRC20.0212</org_study_id>
    <nct_id>NCT04473313</nct_id>
  </id_info>
  <brief_title>Educational Follow-up in COPD Patients After Pulmonary Rehabilitation.</brief_title>
  <acronym>EDURESPI</acronym>
  <official_title>Educational Follow-up in COPD Patients After Pulmonary Rehabilitation: a Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      After pulmonary rehabilitation, the challenge is to maintain the benefits reached during the
      program and increase physical activity.

      As exercise training, education is the corner stone of pulmonary rehabilitation. Education
      allows to support behavioral changes in daily life.

      Recommendations about modalities for maintaining physical activity are still clear, however
      for educational follow up recommendations need to be clarified.

      After a pulmonary rehabilitation program, there is no defined plan for educational follow up
      nor location to perform education session.

      The aim of this study is to evaluate the proportion of patients who succeed to establish and
      maintain the objectives they defined during the pulmonary rehabilitation program, one year
      after this program.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 13, 2020</start_date>
  <completion_date type="Anticipated">August 13, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 13, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Realization of the objective(s) defined by the patient during a common educational assessment (educational diagnosis) at the end end of the pulmonary rehabilitation program</measure>
    <time_frame>one year</time_frame>
    <description>Determination of the objective(s) defined by the patient during a common educational assessment (educational diagnosis) at the end of the pulmonary rehabilitation program and evaluation of the realization of this (these) objective(s) after one year (yes or no)</description>
  </primary_outcome>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        COPD patients, all stages
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD patients COPD patients admitted for pulmonary rehabilitation program in pulmonary
             rehabilitation unit of CH des Pays de Morlaix or CHU Brest

        Exclusion Criteria:

          -  inability to answer to the questionnaire

          -  refusal to participate.

          -  inability to perform the pulmonary rehabilitation program.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Beaumont, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH des pays de Morlaix</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc BEAUMONT</last_name>
    <phone>02 98 62 61 60</phone>
    <email>mbeaumont@ch-morlaix.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Couturaud, MD, PhD</last_name>
      <email>Francis.couturaud@chu-Brest.fr</email>
    </contact>
    <contact_backup>
      <last_name>Eloïse Philippe</last_name>
      <email>eloise.philippe@chu-brest.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Francis Couturaud, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eloïse Philippe</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BEAUMONT</name>
      <address>
        <city>Morlaix</city>
        <zip>29672</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Marc BEAUMONT, PhD</last_name>
      <email>mbeaumont@ch-morlaix.fr</email>
    </contact>
    <contact_backup>
      <last_name>Eloïse Philippe</last_name>
      <email>eloise.philippe@chu-brest.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Catherine Le Ber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Loïc Péran, PT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne Cécile Berriet, PT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc Beaumont, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patricia Le Mevel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Mölken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. doi: 10.1164/rccm.201309-1634ST. Erratum in: Am J Respir Crit Care Med. 2014 Jun 15;189(12):1570.</citation>
    <PMID>24127811</PMID>
  </reference>
  <reference>
    <citation>Péran L, Le Ber C, Pichon R, Cabillic M, Beaumont M. [Follow-up and evaluation of plans developed during pulmonary rehabilitation]. Rev Mal Respir. 2018 Nov;35(9):929-938. doi: 10.1016/j.rmr.2018.08.002. Epub 2018 Sep 7. French.</citation>
    <PMID>30201399</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 13, 2020</study_first_submitted>
  <study_first_submitted_qc>July 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2020</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

